Amarin Corp Plc (AMRN)

[jessellivermore]

raf...

read post 108210

...This covers event risk for differing diagnostic conditions in JELIS...

That is..coronary interventions, heart attacks, heart attacks with coronary interventions...and Angina...

Risk reductions in JELIS secondary prevention 1)EPA vs placebo, EPA 1.8 gms reduced events by 26%...2)NIn patients with a history of heart attack EPA reduced CVD events by 34%..3) In patients with history of MI and intervention EPA cut event risk by 40%...4) In angina patients event risk reduction was only 18%....So Angina actually hurt the over all percent risk reduction...

Please see my other post on the JELIS curves which might answer some of your questions.

Would be nice if some of you actually read some of my posts..You might learn something so you could avoid DA comments that suggest the company might be repeating the Angina mistake...

":>) JL